US5292515A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Manufacture of water-swellable hydrophilic articles and drug delivery devices
Assignee: Endo Pharmaceuticals Solutions Inc
•
Filing: 1993-03-31
•
Granted: 1994-03-08
•
Expires: 2013-03-31
Abstract
Abstract A method of preparing a hydrophilic plastic cartridge by centrifugally casting polymerizable hydrophilic material in a rotating polymerization tube whose longitudinal axis is maintained parallel to the ground. The speed of rotation causes radial outward displacement of the polymerizable material which upon assuming a predetermined shape within the rotating tube is then polymerized to the predetermined solid configuration. The resulting plastic cartridge is characterized by smooth, unscored internal and external cylindrical surfaces. The cartridges are used as a rate-limiting membrane in drug delivery devices. Sterilized kits containing a disposable needle/syringe or trocar-like instrument and the drug delivery device are used for subcutaneous implantation of the device in an animal body.
Inventors
- 👤 Daniel G. Moro
- 👤 Petr Kuzma
- 👤 Harry Quandt
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 14:46
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0087; A61K9/0092; A61K9/0012; A61K9/0019; A61K9/0024; A61M; A61M31/00; A61M31/002; A61M37/00; A61M37/0069; B; B29; B29C; B29C41/00; B29C41/02; B29C41/04; B29C41/042; B29C41/34; B29C41/50
Claims Analysis
Total Claims: 46
Claim 1
Independent Claim
158 words
A method for centrifugally casting a biocompatible, non-biodegradable, water-swellable, water-insoluble, hydrophilic plastic cartridge of uniform wall thickness useful as a rate-limiting barrier in a drug delivery device which comprises: a. rotating a tube comprising a core of smooth uniform cylindrical surface, said tube containing a predetermined quantity of at least one polymerizable hydrophilic liquid monomer and closure means to prevent loss of said liquid monomer during rotation; b. maintaining the longitudinal axis of the rotating tube parallel to the ground and effecting the rotation at a speed sufficient to cause radially outward displacement of said liquid monomer to assume a cylindrically-shaped liquid cartridge having a predetermined configuration within said tube; c. subjecting the tube to polymerization conditions to convert said liquid state cartridge to a solid state hollow plastic cartridge of predetermined configuration; and d. recovering a biocompatible, non-degradable, water-swellable, water-insoluble, hydrophilic cylindrically-shaped plastic cartridge having walls of uniform thickness between its smooth external and internal cylindrical surfaces.
Claim 2
Independent Claim
158 words
A method for centrifugally casting a biocompatible, non-biodegradable, water-swellable, water-insoluble, hydrophilic plastic cartridge of uniform wall thickness useful as a rate-limiting barrier in a drug delivery device which comprises: a. rotating a tube comprising a core of smooth uniform cylindrical surface, said tube containing a predetermined quantity of at least one polymerizable hydrophilic liquid monomer and closure means to prevent loss of said liquid monomer during rotation; b. maintaining the longitudinal axis of the rotating tube parallel to the ground and effecting the rotation at a speed sufficient to cause radially outward displacement of said liquid monomer to assume a cylindrically-shaped liquid cartridge having a predetermined configuration within said tube; c. subjecting the tube to polymerization conditions to convert said liquid state cartridge to a solid state hollow plastic cartridge of predetermined configuration; and d. recovering a biocompatible, non-degradable, water-swellable, water-insoluble, hydrophilic cylindrically-shaped plastic cartridge having walls of uniform thickness between its smooth external and internal cylindrical surfaces.
Claim 3
Dependent Claim
23 words
The method of claim 1 wherein said polymerizable liquid monomer comprises hydrophilic ethylenically unsaturated monomers and an agent to effect the catalysis thereof.
Claim 4
Dependent Claim
21 words
The method of claim 2 wherein the polymerization reaction is carried out in the presence of radiation and a catalyst therefor.
Claim 5
Dependent Claim
24 words
The method of claim 3 wherein said polymerizable liquid monomer contains benzoin methyl ether as an initiator and wherein said radiation is ultra-violet light.
Claim 6
Dependent Claim
32 words
The method of claim 2 wherein the outer portion proximal to the closed end of said cartridge is subjected to a shaving step thereby imparting a smooth oval shape to the cartridge.
Claim 7
Dependent Claim
11 words
The method of claim 5 wherein said cartridge is a xerogel.
Claim 8
Dependent Claim
11 words
The method of claim 6 wherein said cartridge is a hydrogel.
Claim 9
Independent Claim
159 words
The method for the preparation of a delivery device for the sustained release of an active agent therefrom which comprises: a. introducing active agent, and optionally a pharmaceutically acceptable carrier, into a cylindrically-shaped reservoir of a biocompatible, non-biodegradable water-swellable, water-insoluble, cylindrically-shaped plastic cartridge, in an amount sufficient to provide extended sustained release of the active agent, said cartridge having smooth external and internal cylindrical surfaces and a uniform thickness between said surfaces; b. introducing at least one polymerizable liquid monomer into the upper portion of said reservoir in an amount to close the open end of the reservoir, said polymerizable liquid monomer having an equilibrium water content value in its polymerized state which exceeds the equilibrium water content value of said plastic cartridge; and c. polymerizing said polymerizable liquid monomer to effectively seal the opening of the reservoir with a plug of water-swellable, water-insoluble polymer to form a delivery device which give a predetermined release of the active agent.
Claim 10
Independent Claim
159 words
The method for the preparation of a delivery device for the sustained release of an active agent therefrom which comprises: a. introducing active agent, and optionally a pharmaceutically acceptable carrier, into a cylindrically-shaped reservoir of a biocompatible, non-biodegradable water-swellable, water-insoluble, cylindrically-shaped plastic cartridge, in an amount sufficient to provide extended sustained release of the active agent, said cartridge having smooth external and internal cylindrical surfaces and a uniform thickness between said surfaces; b. introducing at least one polymerizable liquid monomer into the upper portion of said reservoir in an amount to close the open end of the reservoir, said polymerizable liquid monomer having an equilibrium water content value in its polymerized state which exceeds the equilibrium water content value of said plastic cartridge; and c. polymerizing said polymerizable liquid monomer to effectively seal the opening of the reservoir with a plug of water-swellable, water-insoluble polymer to form a delivery device which give a predetermined release of the active agent.
Claim 11
Dependent Claim
15 words
The method of claim 8 wherein said plastic cartridge has a smooth, oval cylindrical shape.
Claim 12
Dependent Claim
32 words
The method of claim 8 wherein the outer portion of the delivery device distal to the plug of polymer is subjected to a shaping step to impart a smooth oval shape thereto.
Claim 13
Dependent Claim
12 words
The method of claim 8 wherein said active agent is a drug.
Claim 14
Dependent Claim
21 words
The method of claim 11 wherein said drug is a macromolecular composition having an average molecular weight upwards to about 25,000.
Claim 15
Dependent Claim
15 words
The method of claim 12 wherein said macromolecular composition includes native and recombinant bioactive proteins.
Claim 16
Dependent Claim
14 words
The method of claim 12 wherein said macromolecular composition is a hormonally active polypeptide.
Claim 17
Dependent Claim
14 words
The method of claim 12 wherein said macromolecular composition is luteinizing hormone-releasing hormone polypeptide.
Claim 18
Dependent Claim
19 words
The method of claim 12 wherein said macromolecular composition is a mammalian growth hormone or mammalian growth releasing hormone.
Claim 19
Dependent Claim
12 words
The method of claim 8 wherein said plastic cartridge is a xerogel.
Claim 20
Dependent Claim
12 words
The method of claim 8 wherein said plastic cartridge is a hydrogel.
Claim 21
Dependent Claim
17 words
The method of claim 8 wherein said plastic cartridge is a hydrogel at its equilibrium water content.
Claim 22
Dependent Claim
22 words
The method of claim 17 wherein said polymerizable liquid material comprises an homogenous mixture of ethylenically-unsaturated monomer and a water-soluble pore-forming agent.
Claim 23
Dependent Claim
57 words
As an article, a biocompatible, non-biodegradable, water-swellable, water-insoluble, hydrophilic plastic cartridge useful as a rate-limiting barrier in a drug delivery device capable of being implanted in an animal by perforation, said plastic cartridge characterized by an oval cylindrical shape at its closed end, smooth unscored internal and external cylindrical surfaces, and a uniform thickness between said surfaces.
Claim 24
Dependent Claim
57 words
As an article, a biocompatible, non-biodegradable, water-swellable, water-insoluble, hydrophilic plastic cartridge useful as a rate-limiting barrier in a drug delivery device capable of being implanted in an animal by perforation, said plastic cartridge characterized by an oval cylindrical shape at its closed end, smooth unscored internal and external cylindrical surfaces, and a uniform thickness between said surfaces.
Claim 25
Dependent Claim
16 words
The article of claim 21 wherein the plastic cartridge is in the state of a xerogel.
Claim 26
Dependent Claim
11 words
The article of claim 21 wherein the plastic cartridge is hydrated.
Claim 27
Dependent Claim
15 words
The article of claim 21 wherein the plastic cartridge is a polymer of 2-hydroxyethyl methacrylate.
Claim 28
Dependent Claim
40 words
The article of claim 24 wherein the internal cylindrical surface area proximal to the open end of the cartridge has been scored and treated with a mono- or polyhydric alcohol to enhance graft polymerization of polymerizable ethylenically unsaturated monomer thereto.
Claim 29
Dependent Claim
121 words
A delivery device for the sustained release of an active agent therefrom which comprises: a. biocompatible, non-biodegradable, water-swellable, water-insoluble, hydrophilic plastic cartridge having a cylindrically-shaped reservoir; b. said cartridge characterized by (i) an oval outer cylindrical shape at one end thereof; (ii) smooth internal and external cylindrical surfaces; and (iii) a uniform cylindrical wall thickness; c. sealant means for closure of the open end of said reservoir comprising a plug of biocompatible, non-biodegradable, water-swellable, water-insoluble, hydrophilic polymer having an equilibrium water content value greater than that of the plastic cartridge per se; and d. an active agent contained in the reservoir of the cartridge in an amount sufficient to provide a predetermined sustained release thereof over an extended period of time.
Claim 30
Dependent Claim
121 words
A delivery device for the sustained release of an active agent therefrom which comprises: a. biocompatible, non-biodegradable, water-swellable, water-insoluble, hydrophilic plastic cartridge having a cylindrically-shaped reservoir; b. said cartridge characterized by (i) an oval outer cylindrical shape at one end thereof; (ii) smooth internal and external cylindrical surfaces; and (iii) a uniform cylindrical wall thickness; c. sealant means for closure of the open end of said reservoir comprising a plug of biocompatible, non-biodegradable, water-swellable, water-insoluble, hydrophilic polymer having an equilibrium water content value greater than that of the plastic cartridge per se; and d. an active agent contained in the reservoir of the cartridge in an amount sufficient to provide a predetermined sustained release thereof over an extended period of time.
Claim 31
Dependent Claim
12 words
The delivery of claim 26 wherein said active agent is a drug.
Claim 32
Dependent Claim
22 words
The delivery device of claim 26 wherein said active agent is a macromolecular composition having a molecular weight of upwards to 25,000.
Claim 33
Dependent Claim
19 words
The delivery device of claim 26 wherein said plastic cartridge and said sealant means are in the xerogel state.
Claim 34
Dependent Claim
19 words
The delivery device of claim 26 wherein said plastic cartridge and said sealant means are in the hydrogel state.
Claim 35
Dependent Claim
16 words
The delivery device of claim 26 wherein said active agent includes native and recombinant bioactive proteins.
Claim 36
Dependent Claim
15 words
The delivery device of claim 31 wherein said active agent is a hormonally active polypeptide.
Claim 37
Dependent Claim
15 words
The delivery device of claim 32 wherein said active agent is luteinizing hormone-releasing hormone polypeptide.
Claim 38
Dependent Claim
20 words
The delivery device of claim 26 wherein said active agent is a mammalian growth hormone or mammalian growth releasing hormone.
Claim 39
Dependent Claim
20 words
The delivery device of claim 33 wherein said delivery device contains a pharmaceutically acceptable carrier admixed with the active agent.
Claim 40
Dependent Claim
74 words
A method for the implantation of a small cylindrically-shaped delivery device into an animal for sustained release of an active agent therefrom which comprises: a. perforating the skin of an animal at a preselected site with an instrument comprising a hollow needle and the delivery device of claim 26; b. injecting said delivery device through said hollow needle and depositing it subcutaneously at the preselected site; and c. withdrawing said needle from the animal.
Claim 41
Dependent Claim
15 words
The method of claim 36 wherein said active agent comprises native or recombinant bioactive proteins.
Claim 42
Dependent Claim
15 words
The method of claim 37 wherein said active agent is a luteinizing hormone-releasing hormone polypeptide.
Claim 43
Dependent Claim
16 words
The method of claim 38 wherein the delivery device comprises a cartridge in a zerogel state.
Claim 44
Dependent Claim
16 words
The method of claim 38 wherein the delivery device comprises a cartridge in a hydrated state.
Claim 45
Dependent Claim
66 words
A kit useful for the implantation by perforation of a drug delivery device in an animal for sustained release of a drug therefrom comprising: a. the drug delivery device of claim 37; b. delivery means to eject said drug delivery device to the delivery environment of an animal; and c. container means to house said delivery device and said delivery means in a sterile aqueous medium.
Claim 46
Dependent Claim
66 words
The kit of claim 41 wherein said delivery means comprises a small rigid hollow tube of uniform internal diameter having a needle-like opening at one end thereof, and a telescoping solid rigid rod slidably communicating with the internal surface of said tube, and wherein said drug delivery device positioned within said tube is proximity with one end of the rod for slidable ejection from said tube.
References Cited (Backward Citations)
FR821383A
Cited
US2513014A
Cited
GB1306541A
Cited
US3921632A
Cited
EP0246653A2
Cited
US4959217A
Cited
US4871094A
Cited
US4846793A
Cited
US4994028A
Cited
US5035891A
Cited
US5004614A
Cited
EP0384646A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-03-07 | 1997-09-06 | 1998-03-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-03-07 | 2001-09-06 | 2002-03-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-03-07 | 2005-09-06 | 2006-03-08 | $7700.00 | Window Closed / Lapsed |